Couple who suffered the same cancer awarded $2 billion in Roundup trial
A California jury ordered Bayer - which owns Monsanto - to pay Alva and Alberta Pilliod $2 billion in damages after ruling Roundup weedkiller was to blame for their non-Hodgkin's lymphoma. (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2019 Category: Consumer Health News Source Type: news
Monsanto Expert: 'No Evidence Of Causal Connection' Between Roundup And Cancer
OAKLAND, Calif. - An expert for Monsanto Co. on May 1 testified that "there is no evidence of a causal association between Roundup and non-Hodgkin's lymphoma," as the glyphosate cancer trial of a California couple continued into its 18th day. The parties say that closing arguments are expected May 7 (Alva Pilliod, et al. v. Monsanto Company, No. RG17862702, Calif. Super., Alameda Co.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - May 8, 2019 Category: Medical Law Source Type: news
F.D.A. Won ’t Ban Sales of Textured Breast Implants Linked to Cancer
Many other countries have already banned the products. But the U.S. agency said the risk was still low, despite repeated requests from women and doctors that the implants be removed from the market. (Source: NYT)
Source: NYT - May 6, 2019 Category: American Health Authors: Denise Grady and Roni Caryn Rabin Tags: Breasts Implants Recalls and Bans of Products Food and Drug Administration Plastic Surgery Non-Hodgkin ' s Lymphoma Allergan Inc your-feed-science your-feed-healthcare Source Type: news
N.S. man's Stage 4 cancer is in remission after $900K treatment in Boston
It's too early to know if Stephen Saunders has been cured of non-Hodgkin lymphoma, but he's in remission thanks to a treatment not yet available in Nova Scotia. (Source: CBC | Health)
Source: CBC | Health - May 3, 2019 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news
EPA says glyphosate, the main ingredient in Roundup, doesn't cause cancer
The announcement comes after two high-profile court cases in which cancer patients claimed Roundup, a popular weedkiller containing glyphosate, caused their non-Hodgkin's lymphoma. Jurors awarded both patients tens of millions of dollars. (Source: CNN.com - Health)
Source: CNN.com - Health - May 1, 2019 Category: Consumer Health News Source Type: news
Science Saturday: New genetic test classifies lymphomas
The current diagnostic tools in a pathologist's arsenal sometimes cannot provide a clear distinction between primary mediastinal large B-cell lymphoma (one of the few lymphomas more common in younger women) and diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma overall. This may occasionally give rise to diagnostic inaccuracy in routine practice and could leave [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 26, 2019 Category: Research Source Type: news
Promising Results in Mice Prompt Human Trial of Novel Lymphoma Vaccine Promising Results in Mice Prompt Human Trial of Novel Lymphoma Vaccine
An in situ vaccine (ISV) combined with immune stimulants and radiotherapy showed efficacy in mice, prompting a phase 1 trial of patients with advanced indolent non-Hodgkin ' s lymphoma (INHL), researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Couple that suffered the same cancer after using Roundup for 30 years tells heartbreaking story
Alva and Alberta Pilliod testified this week that they used Monsanto's Roundup for 30 years before they both developed non-Hodgkins lymphoma. They say the weedkiller caused it. (Source: the Mail online | Health)
Source: the Mail online | Health - April 19, 2019 Category: Consumer Health News Source Type: news
Lenalidomide Plus Rituximab Ups Response in Relapsed Indolent Lymphoma Lenalidomide Plus Rituximab Ups Response in Relapsed Indolent Lymphoma
In patients with relapsed or refractory indolent non-Hodgkin lymphoma, adding lenalidomide to rituximab improves response, according to a placebo-controlled trial.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 4, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
Researchers discover how tumor-killing immune cells attack lymphomas in living mice
(Rockefeller University Press) In a study that will be published April 1 in the Journal of Experimental Medicine, researchers from the Institut Pasteur and INSERM reveal that chimeric antigen receptor (CAR) T cells can induce tumor regression by directly targeting and killing cancer cells, uncovering new details of how these immune cells work and how their effectiveness could be improved in the treatment of non-Hodgkin's lymphoma and other B cell cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2019 Category: Cancer & Oncology Source Type: news
California Man Awarded $ 80 Million in Roundup Lawsuit
Jury previously found Roundup was a significant factor in plaintiff ' s non - Hodgkin lymphoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 29, 2019 Category: Cancer & Oncology Tags: Oncology, Pathology, Institutional, Source Type: news
Bayer ordered to pay $81M in Roundup cancer case
A federal jury has ordered Bayer to pay $81 million to a California man who said his use of the company's Roundup weedkiller caused him to develop cancer.
The ruling is the latest against Bayer involving Roundup, which was developed by St. Louis-based Monsanto before the company was acquired by Bayer last year for $62.5 billion.
A San Francisco jury said Wednesday that the company is liable for the man's non-Hodgkin lymphoma, according to Reuters. Edwin Hardeman was awarded $5.9 million in compensatory… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 27, 2019 Category: Pharmaceuticals Authors: Vince Brennan Source Type: news
Bayer ordered to pay $81M in Roundup cancer case
A federal jury has ordered Bayer to pay $81 million to a California man who said his use of the company's Roundup weedkiller caused him to develop cancer.
The ruling is the latest against Bayer involving Roundup, which was developed by St. Louis-based Monsanto before the company was acquired by Bayer last year for $62.5 billion.
A San Francisco jury said Wednesday that the company is liable for the man's non-Hodgkin lymphoma, according to Reuters. Edwin Hardeman was awarded $5.9 million in compensatory… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 27, 2019 Category: Biotechnology Authors: Vince Brennan Source Type: news
Jury rules Monsanto IS liable for man's cancer after his years using Roundup
Edwin Hardeman of Santa Rosa, California, has non-Hodgkin's lymphoma, a cancer of the immune system, after using Roundup to kill poison oak on his 56-acre property over 30 years. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2019 Category: Consumer Health News Source Type: news
Bellwether Glyphosate Cancer Trial Heads To Phase 2 To Determine Liability
SAN FRANCISCO - Phase 2 of the federal bellwether glyphosate cancer trial in California started March 20, after a jury the first phase found that the chemical, which is the active ingredient in Monsanto Co.'s herbicide Roundup, was "a substantial factor" in causing the plaintiff's non-Hodgkin lymphoma (NHL) (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - March 26, 2019 Category: Medical Law Source Type: news